{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-219415","form_type":"8-K","ticker":"LMRI","cik":"0002071288","company_name":"Lumexa Imaging Holdings, Inc.","filed_at":"2026-05-12T20:08:46+00:00","discovered_at":"2026-05-12T20:10:01.364271+00:00","generated_at":"2026-05-12T21:23:44.680906+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Lumexa Q1 rev $252.5M (+3.1%); net income $1.7M vs loss; reaffirms FY guidance","bullets":["Consolidated revenues of $252.5M, up 3.1% YoY; net income $1.7M vs net loss of $7.7M.","GAAP EPS $0.02; Adjusted EPS $0.18; Adjusted EBITDA $51.2M (20.3% margin) vs $51.0M.","Same-center advanced volume growth of 5.6% for both consolidated and system-wide.","Announced four new centers: two tuck-in acquisitions and two de novos; on track for 8-10 de novos in 2026.","FY 2026 guidance reaffirmed: rev $1.045-1.097B, Adj EBITDA $234-242M, Adj EPS $0.71-0.77."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-219415","json":"https://secwatch.observer/filing/0001193125-26-219415.json","markdown":"https://secwatch.observer/filing/0001193125-26-219415.md","text":"https://secwatch.observer/filing/0001193125-26-219415.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2071288/000119312526219415/0001193125-26-219415-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2071288/000119312526219415/d145661d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-12T21:23:44.680906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1236abadb008aee453c741d9dca77767a7725bc4","claim":"Lumexa Imaging Holdings, Inc. reported the first quarter ended March 31, 2026 results: revenue $252.5 million, net income $1.7 million, EPS $0.02 per share. Guidance reaffirmed.","evidence_excerpt":"for patients, providers, and payors.” First Quarter 2026 Highlights: All comparisons are to the quarter ended March 31, 2025, unless otherwise noted • Consolidated revenues of $252.5 million, an increase of 3.1% from $245.0 million • System-wide revenue growth of 4.0% • Same center advanced volume growth: 5.6% for both consolidated and system-wide • Net income of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2071288/000119312526219415/0001193125-26-219415-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$252.5 million"},{"label":"Net income","value":"$1.7 million"},{"label":"EPS","value":"$0.02 per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}